Loyola Medicine is the only center in the Midwest enrolling patients in a landmark clinical trial of a new procedure to treat a life-threatening heart rhythm disorder called ventricular tachycardia.

Baltimore, MD - A report published this week has shown a high rate of ventricular tachycardia (VT) recurrence—as high as 75% at 14 months—in arrhythmogenic right ventricular dysplasia/cardiomyopathy ...

ST LOUIS, MO — Stereotactic delivery of external-beam radiation can potentially be used to ablate the source of ventricular tachycardia (VT) that has resisted other drug and device treatments, ...

Please provide your email address to receive an email when new articles are posted on . High-risk patients getting catheter ablation for ventricular tachycardia did not benefit from a mechanical ...

BERLIN, Germany—Performing ventricular tachycardia (VT) ablation before placement of a primary prevention implantable cardioverter-defibrillator (ICD) had a clinical benefit in a selected group of ...

The Amsterdam UMC team, shown here, performed the VT ablation procedure following previous experiences performing atrial flutter and premature ventricular complex (PVC) ablation procedures guided by ...

vMap’s use with ‘Unmappable’ Ventricular Tachycardia Ablation and Accurate Proof-of-Concept Mapping Using Outpatient 12-lead ECG Data to be Presented at the Heart Rhythm Society’s Annual Conference in ...

Now, Imricor Medical Systems (ASX:IMR) can add its imprint to the Mending Broken Hearts Club, after Dutch surgeons used its cardiac ablation device in a groundbreaking procedure. Imricor has developed ...